Insider Transactions in Q3 2023 at Medifast Inc (MED)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2023
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.67%
|
$810
$81.08 P/Share
|
|
Aug 15
2023
|
Jeffrey J Brown Director |
SELL
Open market or private sale
|
Indirect |
23,162
-71.22%
|
$2,084,580
$90.13 P/Share
|
|
Aug 14
2023
|
Jeffrey J Brown Director |
SELL
Open market or private sale
|
Indirect |
15,154
-39.55%
|
$1,394,168
$92.6 P/Share
|
|
Aug 08
2023
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
37
+0.44%
|
$3,293
$89.42 P/Share
|
|
Aug 08
2023
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
38
+0.61%
|
$3,382
$89.42 P/Share
|
|
Aug 08
2023
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
39
+0.37%
|
$3,471
$89.42 P/Share
|
|
Aug 08
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
44
+0.76%
|
$3,916
$89.42 P/Share
|
|
Aug 04
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
688
+1.59%
|
$68,800
$100.03 P/Share
|
|
Jul 20
2023
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,142
-5.55%
|
$107,348
$94.5 P/Share
|
|
Jul 20
2023
|
James P. Maloney Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,574
+24.9%
|
-
|